rs750085275
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002691.4(POLD1):c.2388+5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000439 in 1,593,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002691.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.2388+5G>A | splice_region_variant, intron_variant | Intron 19 of 26 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000565 AC: 13AN: 229954Hom.: 0 AF XY: 0.0000323 AC XY: 4AN XY: 123700
GnomAD4 exome AF: 0.0000402 AC: 58AN: 1441624Hom.: 0 Cov.: 31 AF XY: 0.0000405 AC XY: 29AN XY: 715364
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74384
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Observed in individuals with personal and/or family history of breast cancer (PMID: 34326862, 34646395, 35534704); This variant is associated with the following publications: (PMID: 34326862, 34646395, 35534704) -
- -
Colorectal cancer, susceptibility to, 10 Uncertain:2
This sequence change falls in intron 19 of the POLD1 gene. It does not directly change the encoded amino acid sequence of the POLD1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs750085275, gnomAD 0.01%). This variant has been observed in individual(s) with breast cancer (PMID: 34646395, 35534704). ClinVar contains an entry for this variant (Variation ID: 408012). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with inconclusive levels of altered splicing (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Hereditary cancer-predisposing syndrome Benign:2
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not specified Uncertain:1
Variant summary: POLD1 c.2388+5G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Four predict the variant weakens the canonical intron 19, 5' splicing donor site. However, these predictions have yet to be confirmed by peer reviewed functional studies. In-house RNA analysis demonstrated inconclusive levels of in-frame skipping of exon 19 resulting in r.2251_2388del (p.Val752_Val797del), however, the in-vivo relevance of this finding is unclear (internal data). To our knowledge, no pathogenic/likely pathogenic variants have been reported in exon 19. The variant allele was found at a frequency of 5.7e-05 in 229954 control chromosomes. The observed variant frequency exceeds the estimated maximal expected allele frequency for a pathogenic variant in POLD1 causing Mandibular Hypoplasia, Deafness, Progeroid Features, And Lipodystrophy Syndrome phenotype (6.3e-07) or susceptibility to colorectal cancer (1.4e-05). c.2388+5G>A has been reported in the literature as a VUS in settings of multigene panel testing for hereditary cancer but has not been reported in individuals with Autosomal Dominant Mandibular Hypoplasia, Deafness, Progeroid Features, And Lipodystrophy Syndrome. The association of POLD1 with Autosomal Recessive Immunodeficiency 120 is limited at this moment and loss of function of POLD1 is not an established mechanism of disease. Therefore, these report(s) do not provide unequivocal conclusions about association of the variant with any of the POLD1-related disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34326862, 34646395, 35534704). ClinVar contains an entry for this variant (Variation ID: 408012). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at